Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial. - Smeijer JD; de Vries ST; Kohan DE; Hou FF; Heerspink HJL (Diabetologia, 2025)